This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The S&P 500 index fund offers wide exposure to major US companies with low costs. This intro covers benefits and considerations for beginners.
22,658 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Investors are hearing a warning bell as markets cling to near-record highs while inflation and geopolitics loom. If a...
A major institutional move in an international ETF is sending a clear message about overseas exposure. Here’s how to ...
Want a disciplined path to growing wealth while earning income? Explore four dividend ETFs poised build long-term wea...
A five-year restraining order against a persistent admirer shows how safety, law, and money intersect. Learn practica...
The latest inflation data show a notable rise that marks the highest level in years. As investors, we can parse the s...
Cardano is facing a challenging period. In this guide, you’ll learn how to assess whether the cardano crisis signals ...
VanEck’s gaming-focused ETF has rebranded to GENZ, shifting to digital-native growth and altering the dividend safety...
As U.S. markets face volatility, a single low-cost ETF offering broad exposure to Europe and Japan is drawing steady ...
Oil markets stole the spotlight in 2026, with crude becoming the defining trade as futures dynamics and supply fears ...
A sizable fund disclosed a multi-million Braze stake as the stock faced a steep drop. This article explains what the ...
A mid-sized fund has quietly built a sizable Porch Group position, signaling conviction in this tech-insurance combo....